Fludeoxyglucose F 18 Positron Emission Tomography in Predicting Risk of Relapse in Patients With Non-Hodgkin's Lymphoma Who Are Undergoing Combination Chemotherapy With or Without Autologous Stem Cell or Bone Marrow Transplant

Clinical trial NCT00238368 · COMPLETED

Trial details

NCT number

NCT00238368

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Status

COMPLETED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2004-02-01

Primary completion

2007-09-17

Enrollment

59

View on ClinicalTrials.gov